Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Debt Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+130.5%
5Y CAGR+9.6%
Year-over-Year Change
Year-over-year debt growth rate
3Y CAGR
+130.5%/yr
Quarterly compound
5Y CAGR
+9.6%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 111.60% |
| Q3 2025 | 20.13% |
| Q2 2025 | -7.38% |
| Q1 2025 | -5.74% |
| Q4 2024 | 2.74% |
| Q3 2024 | 82.44% |
| Q2 2024 | 29.41% |
| Q1 2024 | -10.77% |
| Q4 2023 | 8.55% |
| Q3 2023 | -2.98% |
| Q2 2023 | -2.74% |
| Q1 2023 | -12.28% |
| Q4 2022 | 9.11% |
| Q3 2022 | -2.68% |
| Q2 2022 | -2.89% |
| Q1 2022 | -9.81% |
| Q4 2021 | 10.33% |
| Q3 2021 | -1.91% |
| Q2 2021 | -0.55% |
| Q1 2021 | -3.55% |
| Q4 2020 | 70.52% |
| Q3 2020 | 4.68% |
| Q2 2020 | -2.04% |
| Q1 2020 | -19.45% |
| Q4 2019 | 9.45% |
| Q3 2019 | -1.21% |
| Q2 2019 | -1.91% |
| Q1 2019 | 6.31% |
| Q4 2018 | -0.21% |
| Q3 2018 | -0.79% |
| Q2 2018 | -0.40% |
| Q1 2018 | -1.86% |
| Q4 2017 | 3.28% |
| Q3 2017 | 3.28% |
| Q2 2017 | 3.67% |
| Q1 2017 | -34.77% |
| Q4 2016 | 2.49% |
| Q3 2016 | -0.04% |
| Q2 2016 | -0.47% |
| Q1 2016 | -0.21% |